Wolfgang Miesbach: Grateful to the Organisers and Pfizer for this Invaluable Opportunity
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared on LinkedIn:
“Honoured to have presented virtually at the 2025 Hemophilia Summit in Shenzhen, China on Advancing Shared Decision Making in the Era of Novel Haemophilia Therapies!
The presentation explored how patient values, life stages, and individual priorities should shape treatment goals.
It’s not just about preventing bleeds anymore—it’s about optimising quality of life, preserving joint health, and enabling meaningful participation in everyday activities.
Key themes covered:
- Understanding diverse treatment pathways and their trade-offs
- Recognising life-stage specific needs (childhood, adolescence, adulthood, aging)
- Practical frameworks for eliciting patient priorities and concerns
- Real case studies demonstrating SDM in action—from teenagers transitioning to university to elderly patients with chronic arthropathy
- Transition checklists and decision documentation tools
Delighted to have engaged with colleagues across China and the broader Asian hemophilia community—sharing evidence-based practice whilst learning from clinical experiences and patient perspectives in Asia.
Grateful to the organisers and Pfizer for this invaluable opportunity to contribute to advancing patient-centred care globally.”
Read the full article here.
Follow the latest in Hemostasis Today.
-
Dec 2, 2025, 10:59Catherine Thieblemont: Reappointed as Head of Department – A Joy, A Responsibility, and A Challenge that Remains Intact
-
Dec 2, 2025, 10:06Maeva May Shares Stroke Association’s New Research Strategy that Launched at UKSF2025
-
Dec 2, 2025, 10:00Jennifer Ficenec: What Happens to Blood Products After Hospitals Say No?
-
Dec 2, 2025, 09:55Marilena Vrana Reflects on A Year of Growth, Gratitude, and Collective Strength
-
Dec 2, 2025, 09:51Time to Refocus on NSTEMI․ Why This State-of-the-Art Review Matters
-
Dec 2, 2025, 09:51Arsène Mekinian: Corticosteroid Tapering Strategies Show No Difference
-
Dec 2, 2025, 09:50Joanna Sadowska: Bayer’s Asundexian Reduces Ischemic Stroke Risk in Phase 3 Trial
-
Dec 2, 2025, 09:49George Touma: Sirolimus DCBs Will Eventually Replace Paclitaxel
-
Dec 2, 2025, 09:49Professor Erwin Loh: Amino Acid Reduces Alzheimer’s Plaques